Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.
Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.
复制标题
DOI:
10.1002/hep.28283
复制
发表时间:
2016-01
期刊:
影响因子:
--
通讯作者:
Santoro N
中科院分区:
文献类型:
--
作者:
Goffredo M;Caprio S;Feldstein AE;D'Adamo E;Shaw MM;Pierpont B;Savoye M;Zhao H;Bale AE;Santoro N
To assess the association between the single-nucleotide polymorphism (SNP) rs58542926 in the transmembrane 6 superfamily member 2 (TM6SF2) gene and fatty liver disease in obese youth. We genotyped the TM6SF2 rs58542926 SNP in a multiethnic cohort of 957 obese children and adolescents (42% Caucasians, 28% African Americans, 30% Hispanics). All underwent an oral glucose tolerance test, a liver panel and a lipid profile. Of them, 454 children underwent a MRI study to assess hepatic fat content (HFF%), 11 children underwent liver biopsy to assess the degree of disease severity. The minor allele of the rs58542926 SNP was associated with high HFF% in Caucasians and African Americans (all P<0.05), with high ALT levels in Hispanics (P<0.05) and with a more favorable lipoprotein profile (lower LDL, small dense LDL and very small LDL) in Caucasians and Hispanics (all P<0.05). The liver biopsy showed a higher prevalence of fibrosis (P=0.04) and a higher NAFLD Activity Score (P=0.05) in subjects carrying the minor allele than in those homozygous for the common allele. Moreover, we observed a joint effect among the TM6SF2 rs58542926, the PNPLA3 rs738409 and the GCKR rs1260326 SNPs in determining intrahepatic fat accumulation (P<0.05). The rs58542926 SNP in the TM6SF2 gene is associated with pediatric NAFLD, but may confer protection against cardiovascular risk.